These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23532963)

  • 1. Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer.
    Wang J; Ma L; Weng W; Qiao Y; Zhang Y; He J; Wang H; Xiao W; Li L; Chu Q; Pan Q; Yu Y; Sun F
    Hepatology; 2013 Sep; 58(3):1011-20. PubMed ID: 23532963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.
    Zhang T; Zhang J; You X; Liu Q; Du Y; Gao Y; Shan C; Kong G; Wang Y; Yang X; Ye L; Zhang X
    Hepatology; 2012 Dec; 56(6):2051-9. PubMed ID: 22707013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer.
    Li L; Wang J; Zhang Y; Zhang Y; Ma L; Weng W; Qiao Y; Xiao W; Wang H; Yu W; Pan Q; He Y; Sun F
    FEBS Lett; 2013 Dec; 587(24):3921-7. PubMed ID: 24211253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutual interaction between YAP and c-Myc is critical for carcinogenesis in liver cancer.
    Xiao W; Wang J; Ou C; Zhang Y; Ma L; Weng W; Pan Q; Sun F
    Biochem Biophys Res Commun; 2013 Sep; 439(2):167-72. PubMed ID: 23994632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma.
    Wang J; Tang X; Weng W; Qiao Y; Lin J; Liu W; Liu R; Ma L; Yu W; Yu Y; Pan Q; Sun F
    Oncogene; 2015 Nov; 34(47):5781-95. PubMed ID: 25728681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis.
    Zhang X; Qiao Y; Wu Q; Chen Y; Zou S; Liu X; Zhu G; Zhao Y; Chen Y; Yu Y; Pan Q; Wang J; Sun F
    Nat Commun; 2017 May; 8():15280. PubMed ID: 28474680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUAK2 is a critical YAP target in liver cancer.
    Yuan WC; Pepe-Mooney B; Galli GG; Dill MT; Huang HT; Hao M; Wang Y; Liang H; Calogero RA; Camargo FD
    Nat Commun; 2018 Nov; 9(1):4834. PubMed ID: 30446657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cAMP response element-binding protein and Yes-associated protein form a feedback loop that promotes neurite outgrowth.
    Chen L; Feng P; Peng A; Qiu X; Zhu X; He S; Zhou D
    J Cell Mol Med; 2018 Jan; 22(1):374-381. PubMed ID: 28857442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT1 increases YAP- and MKK3-dependent p38 phosphorylation in mouse liver and human hepatocellular carcinoma.
    Wang Y; Cui R; Zhang X; Qiao Y; Liu X; Chang Y; Yu Y; Sun F; Wang J
    Oncotarget; 2016 Mar; 7(10):11284-98. PubMed ID: 26824501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway.
    Yang N; Chen T; Wang L; Liu R; Niu Y; Sun L; Yao B; Wang Y; Yang W; Liu Q; Tu K; Liu Z
    Theranostics; 2020; 10(13):5790-5801. PubMed ID: 32483419
    [No Abstract]   [Full Text] [Related]  

  • 11. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
    Wong KF; Liu AM; Hong W; Xu Z; Luk JM
    Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis.
    Chen R; Zhu S; Fan XG; Wang H; Lotze MT; Zeh HJ; Billiar TR; Kang R; Tang D
    Hepatology; 2018 May; 67(5):1823-1841. PubMed ID: 29149457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cluster of differentiation 166 (CD166) regulated by phosphatidylinositide 3-Kinase (PI3K)/AKT signaling to exert its anti-apoptotic role via yes-associated protein (YAP) in liver cancer.
    Ma L; Wang J; Lin J; Pan Q; Yu Y; Sun F
    J Biol Chem; 2014 Mar; 289(10):6921-6933. PubMed ID: 24482231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumorigenic role of YAP in hepatocellular carcinogenesis is involved in SHP2 whose function is different in vitro and in vivo.
    Kim MK; Park JY; Kang YN
    Pathol Res Pract; 2018 Jul; 214(7):1031-1039. PubMed ID: 29699904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver.
    Li X; Tao J; Cigliano A; Sini M; Calderaro J; Azoulay D; Wang C; Liu Y; Jiang L; Evert K; Demartis MI; Ribback S; Utpatel K; Dombrowski F; Evert M; Calvisi DF; Chen X
    Oncotarget; 2015 Apr; 6(12):10102-15. PubMed ID: 25826091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ.
    Zhu H; Yan F; Yuan T; Qian M; Zhou T; Dai X; Cao J; Ying M; Dong X; He Q; Yang B
    Cancer Res; 2020 Jun; 80(11):2204-2216. PubMed ID: 32217697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.
    Liu Y; Zhang X; Lin J; Chen Y; Qiao Y; Guo S; Yang Y; Zhu G; Pan Q; Wang J; Sun F
    Cell Death Dis; 2019 Sep; 10(9):644. PubMed ID: 31501420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis.
    Yi C; Shen Z; Stemmer-Rachamimov A; Dawany N; Troutman S; Showe LC; Liu Q; Shimono A; Sudol M; Holmgren L; Stanger BZ; Kissil JL
    Sci Signal; 2013 Sep; 6(291):ra77. PubMed ID: 24003254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells.
    Yu W; Qiao Y; Tang X; Ma L; Wang Y; Zhang X; Weng W; Pan Q; Yu Y; Sun F; Wang J
    Cell Signal; 2014 Dec; 26(12):2961-8. PubMed ID: 25261601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer.
    Wang J; Wang H; Zhang Y; Zhen N; Zhang L; Qiao Y; Weng W; Liu X; Ma L; Xiao W; Yu W; Chu Q; Pan Q; Sun F
    Cell Signal; 2014 May; 26(5):1048-59. PubMed ID: 24468535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.